YTHDC1 and metabolic dysfunction-associated steatohepatitis: Hepatocyte‐specific deletion of Ythdc1 results in hepatocyte immaturity, leading to reduced liver weight, liver injury, inflammation, and fibrosis, which in turn promotes the pathogenesis of NASH and HCC.